Sponsor delegation for IVD first-in-human clinical performance study and evaluation
Empower your clinical studies with our completely managed outsourced IVD clinical study sponsor package
In the critical phase of first-in-human medicinal product trials, attention to detail, compliance and efficiency are crucial. By delegating your IVD clinical study sponsor responsibilities to ARC, you gain a trusted partner with the expertise and resources to seamlessly initiate and manage your study, while you are still in control and continue acting as a sponsor.
Key Components of our IVD Clinical Study Sponsor Delegation Package
Under our complete managed outsourcing model, we will work as your pharma clinical trial sponsor extension for your IVD performance study, with clearly identified integration points.
Systems and people will connect seamlessly to deliver on the overall objectives of your IND/IMP and IVD studies.
As your IVD clinical evaluation sponsor we will take care of:
ARC IVD Clinical Study Sponsor Comprehensive Services
We provide a full suite of services tailored to support your first-in human (FiH) trials involving IVDs.
Our completely managed outsourced IVD study sponsor package includes:
Why choose ARC as your clinical study sponsor partner
We are a trusted market leader in regulatory, quality, and clinical operations, with extensive experience supporting the full clinical development life cycle of precision therapies for global pharmaceutical companies. As a full-service CRO, we are fully equipped to meet IVD clinical trials sponsor responsibilities and obligations while, our commitment to excellence, ensures that we consistently deliver high-quality results.
Advantages of working with us as your IVD clinical evaluation sponsor:
Why delegate Sponsor Responsibility to ARC?
- Competence in this ‘niche’ area
- Real world experience in IVD sponsor responsibilities
- QMS process know-how
- Sponsor oversight and management
- GCP monitoring
- Pharma sponsor extension
- Clear roles and responsibilities
- Regulatory and compliance experience
- Extensive clinical monitoring experience
What our customers have to say:
”Partnering with ARC was a transformative decision. Their deep knowledge and expertise of regulatory requirements in global markets for IVDs in precision medicine trials, along with their open and collaborative approach, ensured a smooth and successful trial.”
A leading, global pharmaceutical company